FDA announces recall of Philips defibrillators
The FDA announced that roughly 5,400 HeartStart FR2+ automated external defibrillators made by Philips have been recalled because they may carry a defective memory chip that can render the life-saving devices inoperable. Although there have been reports of the memory chips in some of the defibrillators failing during routine self tests, none of them have failed during emergencies and caused patient injuries or deaths.
-
FDA Issues Class I Recall for Physio-Control’s LifePak 20/20e Defibrillators
Philips introduces advancements in Xcelera system
Life Recovery Systems gets FDA nod for ThermoSuit study
FDA Urgently Recalls AED Battery
Medtronic Announces First European Implant Of New Drug-Eluting Stent At Southampton General Hospital, UK
